Month: January 2025

Metsera Announces Pricing of Initial Public Offering

Written by Customer Service on January 30, 2025. Posted in Public Companies.

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, overweight and related conditions, today announced the pricing of its initial public offering of 15,277,778 shares of its common stock at a price to the public of $18.00 per share. All of the shares of common stock are being offered by Metsera. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Metsera, are expected to be approximately $275.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. Metsera’s common stock is expected to begin trading on the Nasdaq Global Select...

Alpine Banks of Colorado announces financial results for fourth quarter and year end 2024

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

GLENWOOD SPRINGS, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the fourth quarter and year ended December 31, 2024. The Company reported net income of $13.8 million, or $128.92 per basic Class A common share and $0.86 per basic Class B common share, for fourth quarter 2024. Highlights in fourth quarter 2024 and the year ended December 31, 2024, include:Basic earnings per Class A common share increased 1.4%, or $1.76, during fourth quarter 2024. Basic earnings per Class A common share decreased 12.0%, or $63.32, during the 12 months ended December 31, 2024. Basic earnings per Class B common share increased 1.4%, or $0.01, during fourth quarter 2024. Basic earnings per Class B...

Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the second quarter ended December 31, 2024. ACTIVITY REPORT On December 18, 2024, Ryoncil® (remestemcel-L) became the first mesenchymal stromal cell (MSC) therapy approved by U.S. FDA for any indication. FDA approved Ryoncil® as the first and only therapy for children aged 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), a life-threatening condition with high mortality rates. Commercial inventory has been manufactured and a distribution network has been established using Cencora, a leader in specialty pharmaceutical services and distribution....

Celestica Announces 2025 Annual and Special Meeting of Shareholders

Written by Customer Service on January 30, 2025. Posted in Public Companies.

TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) — Celestica Inc. (TSX: CLS) (NYSE: CLS) (“Celestica” or the “Company”), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced that the Annual and Special Meeting of its Shareholders (the “Meeting”) will be held on Tuesday, June 17, 2025 at 9:30 a.m. EDT in a hybrid format, with further details to be provided in the Company’s upcoming definitive proxy statement related to the Meeting. Record Date Celestica also announced that it has set Tuesday, April 22, 2025 as the record date for determining shareholders of the Company who are entitled to receive notice of, and to vote at, the Meeting. Notice-and-Access Celestica will be using the notice-and-access method for delivering the Company’s proxy statement and...

Dorel Announces Major Home Segment Restructuring

Written by Customer Service on January 30, 2025. Posted in Public Companies.

Dorel Home adjusting to market realities Dorel Juvenile continues to gain market share and improve earnings Additional financing options being exploredMONTRÉAL, Jan. 30, 2025 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today announced a significant restructuring of the Home segment. This strategic move is part of the Company’s efforts to realign its business model to current and anticipated future industry dynamics and the reality that revenue expectations for the Home segment require a much smaller footprint than in the past. Given the importance of this restructuring, the update holds considerable relevance for both the upcoming fourth quarter results, to be released on March 11, 2025, and the expectations for the 2025 fiscal year. Context and BackgroundThe furniture industry, like many others, has experienced...

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Written by Customer Service on January 30, 2025. Posted in Public Companies.

HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announces the closing of its previously announced “reasonable best efforts” public offering with participation from the Company’s Chief Executive Officer, certain board members, and existing institutional investors of the Company, along with a healthcare focused institutional investor, consisting of 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A warrants to purchase up to 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and Series B warrants to purchase up to 4,025,336 shares of common stock...

Koss Corporation Reports Profitable Second Quarter Results

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

MILWAUKEE, Jan. 30, 2025 (GLOBE NEWSWIRE) — Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the second quarter ended December 31, 2024. For the three months ended December 31, 2024, net sales were $3,557,086 compared to $3,360,124 for the same three-month period in the prior year, an increase of $196,962 or 5.9%. Net income for the second quarter ended December 31, 2024 was $94,142 compared to a net loss of $269,153 for the second quarter of the prior fiscal year. Basic and diluted net income per common share for the second quarter of fiscal year 2025 was $0.01 compared to basic and diluted net loss per common share of $0.03 for the same three-month period one year ago. Net sales of $6,758,954 for the six months ended December 31, 2024 were up slightly...

Gentherm Announces Date for 2024 Fourth Quarter and Year-End Results News Release and Conference Call

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

NORTHVILLE, Mich., Jan. 30, 2025 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, will report its financial results for the fourth quarter and year-end 2024 on Wednesday, February 19, 2025, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13751539 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm’s website at www.gentherm.com. A telephonic replay will be available approximately two hours after the call...

Home Federal Bancorp, Inc. of Louisiana Reports Results of Operations for the Three and Six Months Ended December 31, 2024

Written by Customer Service on January 30, 2025. Posted in Earnings Releases And Operating Results.

Shreveport, La, Jan. 30, 2025 (GLOBE NEWSWIRE) — Home Federal Bancorp, Inc. of Louisiana (the “Company”) (Nasdaq: HFBL), the holding company of Home Federal Bank, reported net income for the three months ended December 31, 2024, of $1.02 million compared to net income of $1.00 million reported for the three months ended December 31, 2023. The Company’s basic and diluted earnings per share were $0.33 for the three months ended December 31, 2024 and December 31, 2023. The Company reported net income of $2.0 million for the six months ended December 31, 2024, compared to $2.2 million for the six months ended December 31, 2023. The Company’s basic and diluted earnings per share were $0.64 for the six months ended December 31, 2024 compared to $0.73 and $0.72, respectively, for the six months ended December 31, 2023. The Company reported...

Baker Hughes Announces Fourth-Quarter and Full-Year 2024 Results

Written by Customer Service on January 30, 2025. Posted in Public Companies.

Fourth-quarter highlightsOrders of $7.5 billion, including $3.8 billion of IET orders. RPO of $33.1 billion, including IET RPO of $30.1 billion. Revenue of $7.4 billion, up 8% year-over-year. GAAP diluted EPS of $1.18 and adjusted diluted EPS* of $0.70. Adjusted EBITDA* of $1,310 million, up 20% year-over-year. Cash flows from operating activities of $1,189 million and free cash flow* of $894 million.Full-year highlightsOrders of $28.2 billion, including $13.0 billion of IET orders. Revenue of $27.8 billion, up 9% year-over-year. Attributable net income of $2,979 million. GAAP diluted EPS of $2.98 and adjusted diluted EPS* of $2.35. Adjusted EBITDA* of $4,591 million, up 22% year-over-year. Cash flows from operating activities of $3,332 million and free cash flow* of $2,257 million. Returns to shareholders of $1,320 million, including...

Month: January 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals